# Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis

> **NCT04029649** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Fakultas Kedokteran Universitas Indonesia** · enrollment: 204 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Beta-1,3/1,6-D-Glucan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04029649
- **Lead sponsor:** Fakultas Kedokteran Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2019-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04029649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04029649, "Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT04029649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*